Kazia Therapeutics Limited (KZIA) 追踪市盈率为负值 -1.8, 表示公司目前在过去十二个月 (TTM) 基础上处于亏损状态。 前瞻市盈率 143.9 基于分析师预估，预计将恢复盈利。 追踪盈利收益率为 -56.85%, 前瞻盈利收益率 0.70%. PEG 0.02 (Peter Lynch 低估标准 ≤1.0).
本页证实的标准:
SharesGrow 综合评分： 47/100 其中 3/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -3.7 | 0.65 | 1.32 | 11.01 | - |
| 2017 | -2.1 | 0.11 | 0.90 | 2.60 | - |
| 2018 | -3.3 | 0.07 | 1.05 | 1,539.11 | - |
| 2019 | -2.2 | -0.05 | 1.59 | 14,421.39 | - |
| 2020 | -3.0 | 0.46 | 2.65 | 37.88 | - |
| 2021 | -18.4 | 0.33 | 4.09 | 10.19 | - |
| 2022 | -3.2 | -0.02 | 4.41 | 8,060.35 | - |
| 2023 | -1.6 | 0.04 | 2.66 | 57,807.50 | - |
| 2024 | -0.3 | 0.00 | -0.78 | 3.38 | - |
| 2025 | -0.5 | 0.01 | -1.26 | 248.45 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-135.20 | $4.07M | $-12.06M | -296.3% |
| 2017 | $-109.30 | $8.79M | $-10.67M | -121.4% |
| 2018 | $-59.80 | $13.11K | $-6.04M | -46071.1% |
| 2019 | $-85.60 | $1.57K | $-10.27M | -656230% |
| 2020 | $-81.75 | $1.06K | $-12.47M | -1175023.6% |
| 2021 | $-35.80 | $15.18M | $-8.42M | -55.5% |
| 2022 | $-93.05 | $25.00 | $-24.65M | -98591260% |
| 2023 | $-55.55 | $555.00 | $-20.47M | -3687419.8% |
| 2024 | $-55.85 | $2.31M | $-26.78M | -1160.2% |
| 2025 | $-18.90 | $42K | $-20.7M | -49290.5% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $-0.01 | $-0.01 – $-0.01 | $106.62K | $106.62K – $106.62K | 1 |
| 2027 | $-0.55 | $-0.55 – $-0.55 | $62.3K | $62.3K – $62.3K | 1 |
| 2028 | $-0.52 | $-0.52 – $-0.52 | $1.99M | $1.99M – $1.99M | 1 |
| 2029 | $0.07 | $0.07 – $0.07 | $32.84M | $32.84M – $32.84M | 1 |
| 2030 | $4.28 | $4.28 – $4.28 | $97.41M | $97.41M – $97.41M | 1 |
